Enliven Therapeutics, Inc. (ELVN)

49.45 -0.79 (-1.57%) USD  |  NASDAQ  |  Sep 18, 16:00
49.45 0.00 (0.00%) After-Hours: 20:00
More

Enliven Therapeutics EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for ELVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Fiscal Year Chart
Start Trial

Historical EPS Estimates for Next Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 18, 2026 --
August 17, 2026 --
August 06, 2026 --
July 01, 2026 --
June 11, 2026 --
June 08, 2026 --
June 02, 2026 --
Date Value
May 11, 2026 --
May 08, 2026 --
March 25, 2026 --
March 24, 2026 --
March 04, 2026 --
May 29, 2025 --
August 16, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

View EPS Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Fiscal Year Benchmarks

View EPS Estimates for Next Fiscal Year Benchmarks
Start Trial
Definium Therapeutics, Inc. Upgrade
Cocrystal Pharma, Inc. Upgrade
CNBX Pharmaceuticals, Inc. --
GB Sciences, Inc. --
Arvinas, Inc. Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade